MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Potential BlockBuster Technology and/or Business Model
Vivodyne
Organization & Developments: Vivodyne
Parents
Vivodyne
Children
*Pharmaceutical companies historically have spent millions on clinical trials destined to fail 95% of the time because animal models are poor predictors of human biology.
*Platform designed to provide a more accurate and efficient method for preclinical drug testing.
*Utilizes lab-grown human organ models, coupled with advanced robotics and artificial intelligence to obtain clinically predictive data
*Vivodyne is rendering inaccurate animal testing obsolete, using automated robotic platforms and AI to grow and analyze thousands of fully functional human tissues.
2025: Vivodyne to Replace Animal Testing With $40 Million Funding to Reverse 95% Clinical Trial Failure Rate
Jumps
Finance & Acquisition: Vivodyne
Key People: Vivodyne